Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Iscience
|
March 9, 2026
Exogenous sphingomyelinase mediates MSC-derived EV biogenesis and enhances potency via repackaging of molecular cargo
Daniel C Shah, S'Dravious A DeVeaux, Hongmanlin Zhang, et al.
Diagnostics (Basel, Switzerland)
|
September 28, 2021
A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer
Vittorio Branchi, Laura Esser, Corinna Boden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2004
Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients
Martin G Friedrich, Daniel J Weisenberger, Jonathan C Cheng, et al.
Human Pathology
|
October 15, 2024
Expression of the large amino acid transporter SLC7A5/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinoma
Vittorio Branchi, Racha Hosni, Lukas Kiwitz, et al.
Plos One
|
September 23, 2025
Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical note
Anna-Laura Potthoff, Meng-Chun Hsieh, Ahmad Melhem, et al.
Neuroscience and Biobehavioral Reviews
|
November 27, 2022
Neural systems underlying RDoC social constructs: An activation likelihood estimation meta-analysis
Rosario Pintos Lobo, Katherine L Bottenhorn, Michael C Riedel, et al.
Molecular Cancer Therapeutics
|
July 9, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma
Racha Hosni, Niklas Klümper, Christine Sanders, et al.
Molecular Cancer Therapeutics
|
June 13, 2025
The antibody-drug conjugate sacituzumab govitecan (IMMU-132) represents a potential novel therapeutic strategy in cholangiocarcinoma
Racha Hosni, Niklas Klümper, Christine Sanders, et al.
Oncogene
|
June 26, 2022
Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer
Samikshan Dutta, Navatha Shree Polavaram, Ridwan Islam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2024
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF<sup>V600E</sup> wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial
D Ciardiello, L Boscolo Bielo, S Napolitano, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Iscience
|
March 9, 2026
Exogenous sphingomyelinase mediates MSC-derived EV biogenesis and enhances potency via repackaging of molecular cargo
Daniel C Shah, S'Dravious A DeVeaux, Hongmanlin Zhang, et al.
Diagnostics (Basel, Switzerland)
|
September 28, 2021
A Combined TLR7/TLR9/GATA3 Score Can Predict Prognosis in Biliary Tract Cancer
Vittorio Branchi, Laura Esser, Corinna Boden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2004
Detection of methylated apoptosis-associated genes in urine sediments of bladder cancer patients
Martin G Friedrich, Daniel J Weisenberger, Jonathan C Cheng, et al.
Human Pathology
|
October 15, 2024
Expression of the large amino acid transporter SLC7A5/LAT1 on immune cells is enhanced in primary sclerosing cholangitis-associated cholangiocarcinoma and correlates with poor prognosis in cholangiocarcinoma
Vittorio Branchi, Racha Hosni, Lukas Kiwitz, et al.
Plos One
|
September 23, 2025
Flow cytometry protocol for cell death analysis in glioblastoma organoids: A technical note
Anna-Laura Potthoff, Meng-Chun Hsieh, Ahmad Melhem, et al.
Neuroscience and Biobehavioral Reviews
|
November 27, 2022
Neural systems underlying RDoC social constructs: An activation likelihood estimation meta-analysis
Rosario Pintos Lobo, Katherine L Bottenhorn, Michael C Riedel, et al.
Molecular Cancer Therapeutics
|
July 9, 2025
The Antibody-Drug Conjugate Sacituzumab Govitecan (IMMU-132) Represents a Potential Novel Therapeutic Strategy in Cholangiocarcinoma
Racha Hosni, Niklas Klümper, Christine Sanders, et al.
Molecular Cancer Therapeutics
|
June 13, 2025
The antibody-drug conjugate sacituzumab govitecan (IMMU-132) represents a potential novel therapeutic strategy in cholangiocarcinoma
Racha Hosni, Niklas Klümper, Christine Sanders, et al.
Oncogene
|
June 26, 2022
Neuropilin-2 regulates androgen-receptor transcriptional activity in advanced prostate cancer
Samikshan Dutta, Navatha Shree Polavaram, Ridwan Islam, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
August 30, 2024
Comprehensive genomic profiling by liquid biopsy captures tumor heterogeneity and identifies cancer vulnerabilities in patients with RAS/BRAF<sup>V600E</sup> wild-type metastatic colorectal cancer in the CAPRI 2-GOIM trial
D Ciardiello, L Boscolo Bielo, S Napolitano, et al.
Page
of 6